Safeguarding Therapeutics Act report (to accompany H.R. 5663).
Saved in:
Main Author: | United States. Congress. House. Committee on Energy and Commerce, |
---|---|
Format: | eBook |
Language: | English |
Published: |
[Washington, D.C.] :
[U.S. Government Publishing Office],
[2020]
|
Physical Description: |
1 online resource (31 pages). |
Series: |
Report / 116th Congress, 2d session, House of Representatives ;
116-512. |
Subjects: | |
Online Access: |
https://purl.fdlp.gov/GPO/gpo148908 |
In Prospector
Similar Items
-
Safe Doses Act, the Counterfeit Drug Penalty Enhancement Act of 2011, and the Foreign Counterfeit Prevention Act hearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Twelfth Congress, second session, on H.R. 4223, H.R. 3668, and H.R. 4216, March 28, 2012
by: United States. Congress. House. Committee on the Judiciary. Subcommittee on Crime, Terrorism, and Homeland Security.
Published: (2012) -
Counterfeit Drug Penalty Enhancement Act of 2012 report (to accompany H.R. 3668) (including cost estimate of the Congressional Budget Office)
by: United States. Congress. House. Committee on the Judiciary.
Published: (2012) -
Counterfeit Drug Penalty Enhancement Act of 2012 report (to accompany H.R. 3668) (including cost estimate of the Congressional Budget Office)
by: United States. Congress. House. Committee on the Judiciary.
Published: (2012) -
Safeguarding America's Pharmaceuticals Act of 2013 : report together with dissenting views (to accompany H.R. 1919) (including cost estimate of the Congressional Budget Office)
by: United States. Congress. House. Committee on Energy and Commerce,
Published: (2013) -
Safeguarding America's Pharmaceuticals Act of 2013 : report together with dissenting views (to accompany H.R. 1919) (including cost estimate of the Congressional Budget Office)
by: United States. Congress. House. Committee on Energy and Commerce,
Published: (2013)